Toyama antihypertensive therapy with Olmesartan in Post-Stroke patients (TOPS) study
Phase 4
Recruiting
- Conditions
- Hypertension, Post-stroke
- Registration Number
- JPRN-UMIN000009790
- Lead Sponsor
- niversity of Toyama
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Myocardial infarction, cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, unknown type of stroke within previous 6 months (TIA can be registerd) Grade III hypertension (systolic BP>=180mmHg or diastolic BP>=110mmHg) Percutaneous or surgical coronary intervention (PCI, CABG etc.), severe heart failure within 6 months Percutaneous or surgical coronary intervention planned Persistent or permanent atrial fibrillation History of congenital heart disease, rheumatic heart disease, moderate or severe valvular heart disease Unstable angina, severe arrhythmia Pregnant, possible to pregnancy Not appropriate to long term observation Difficult to obtain consent because of minors or dementia etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation at 12 week and 24 week after 1) Blood pressure self-measured at home (home BP) in the early morning and evening, Morning/Evening ratio 2) Blood pressure at hospital (hospital BP) 3) The achievement rate of target blood pressures (at hospital and home)
- Secondary Outcome Measures
Name Time Method